The honest bottom line comes first: MGF has no dose in the clinical sense, because it is sold research-use-only, which means no drug regulator has evaluated it, no controlled human trial stands behind any figure, and no medical authority has authorized a quantity for administration. What the published and supply-channel record does describe is a physical handling pattern shared by most research peptides: a lyophilized powder reconstituted in bacteriostatic water and kept cold. The material's defining quirk is a circulating half-life on the order of minutes, which is the only technical reason timing is discussed at all.
MGF is sold research-use-only with no approved clinical dose, and the descriptive handling record covers a lyophilized powder reconstituted in bacteriostatic water and stored cold, for a peptide whose circulating half-life is measured in minutes.
Research-grade MGF almost always arrives as a lyophilized powder, freeze-dried from solution under vacuum so the water leaves by sublimation while the peptide stays frozen, leaving a dry white cake at the bottom of a sealed vial. The dry state dominates for one reason: a peptide suspended in water is open to hydrolysis, aggregation, and microbial spoilage, and all three of those pathways slow sharply once the water is gone, so the dry vial survives shipping and shelf time that would ruin a pre-mixed solution.
Research-grade MGF is distributed almost exclusively as a lyophilized powder because removing water slows the hydrolysis, aggregation, and microbial degradation that would spoil a pre-mixed solution during shipping and storage.
Reconstitution is the descriptive process of returning the dry cake to solution by adding a measured volume of liquid, and the conventions reported for MGF mirror those for research peptides generally rather than any medical procedure. What makes the description meaningful is measurement: the whole point of a graduated syringe or calibrated pipette is that an error in the added volume propagates directly into every later portion pulled from the vial.
The reconstitution described for MGF introduces a measured diluent slowly down the vial wall and mixes by gentle swirling, with the final concentration set entirely by labeled peptide mass divided by the volume of water added.
The diluent that dominates MGF descriptions is bacteriostatic water, sterile water carrying roughly 0.9% benzyl alcohol, an additive that suppresses bacterial growth so a rubber-stoppered vial can be entered more than once without the contents spoiling between uses. A point that is easy to misread is that the diluent volume changes only the concentration and never the total peptide in the vial, since the labeled mass is fixed once the powder is made.
| Diluent property | Bacteriostatic water | Sterile water for injection |
|---|---|---|
| Preservative | ~0.9% benzyl alcohol | None |
| Vial reuse | Repeated entry over time | Single-use handling |
| Microbial control | Suppresses bacterial growth | No barrier once punctured |
Bacteriostatic water, which carries roughly 0.9% benzyl alcohol, dominates MGF reconstitution because its preservative allows a multi-use vial to be entered repeatedly, unlike preservative-free sterile water for injection.
Storage of MGF is governed almost entirely by temperature, and the descriptions split cleanly between the dry state and the reconstituted state. The dividing line is water itself: hydrolysis and microbial spoilage both need water to proceed, so the dry vial outlasts the mixed one by a wide margin, and light and humidity are the secondary factors the standard picture guards against.
Dry lyophilized MGF is reported stable for months to a year when refrigerated or frozen, while a reconstituted vial is treated as short-lived, with a usable window measured in weeks under steady refrigeration.
The single most distinctive handling feature of MGF is how quickly it disappears from circulation: the standard, non-modified peptide is reported to have a biological half-life on the order of only a few minutes, a consequence of its short amino acid sequence being cleared rapidly by peptidases. That brevity is the technical reason any timing discussion surfaces at all, and it is why a PEGylated version exists as a separate variant, since attaching polyethylene glycol chains shields the peptide and extends its circulating time enough that the two forms are handled as genuinely different materials.
| Property | Unmodified MGF | PEGylated MGF |
|---|---|---|
| Circulating half-life | Order of minutes | Substantially extended |
| Clearance | Rapid peptidase breakdown | Shielded by PEG chains |
| Handling status | Short-burst research material | Treated as a distinct variant |
The unmodified MGF peptide carries a biological half-life on the order of minutes, cleared rapidly by peptidases, which is why a PEGylated variant with a much longer circulating time is treated as a genuinely separate material.
Numeric figures do circulate for MGF in forums, hobbyist guides, and vendor-adjacent writing, and characterizing them honestly means being clear about where they come from and what they are not. They originate from anecdote and from loose reasoning around the known short half-life, not from controlled research designed to establish a safe or effective amount, so their evidentiary standing is effectively nil.
The numeric MGF figures circulating in forums originate from anecdote and loose half-life reasoning rather than controlled human trials, so research-use-only status leaves them with no validated dosing authority.
The reason no approved clinical dosing exists for MGF is fundamentally regulatory rather than technical, and it starts with the research-use-only designation the material carries. Research-use-only labeling formally means the substance is sold for laboratory investigation and is not evaluated, approved, or authorized for administration to humans or animals, so it has never been assigned an approved dose by any drug regulator.
MGF carries no approved clinical dose because its research-use-only status keeps it outside the multi-phase trial pathway that would validate one, and anti-doping authorities also list growth factors of its class as prohibited substances.
An unregulated supply chain is the source of the most serious quality concerns around MGF, because without a regulator policing manufacture there is no external guarantee that a vial contains what its label claims. Identity and labeled mass in particular cannot be taken at face value, and that uncertainty corrodes any attempt to reason about a consistent amount of peptide, since every downstream number inherits the doubt about what the powder actually is.
Because no regulator polices an unregulated supply chain, a vial's identity and labeled mass cannot be assumed, and third-party HPLC and mass spectrometry testing is described as the only real verification of the peptide.
Even setting aside the identity of the material itself, the mechanics of preparing and measuring a reconstituted peptide introduce their own variability, and these errors tend to compound rather than cancel. Because concentration is defined entirely by mass divided by volume, a small slip anywhere in that chain shifts the true peptide content of every portion drawn later, which is what turns a handling error into a measurement error.
Inaccurate diluent volume, misread graduations, surface adsorption, and incomplete dissolution each shift the true peptide content of a reconstituted MGF portion, and an inaccurate labeled mass propagates that error into every downstream measurement.
Educational use only. This article describes what the published scientific and clinical literature reports about MGF. It is not medical advice, and it does not recommend, prescribe, or tell anyone to use anything described here. The regulatory status shown at the top of this page reflects what the record showed on the date given there and can change. mdpep.com does not sell any substance described here, does not endorse human use of it, and does not direct anyone to obtain it.
This is not guidance for your situation. Nothing here accounts for your medical history, your current medications, or anything else specific to you, and none of it should be used to make a decision about your own health.
Affiliate disclosure. Some links on this site are affiliate links, and mdpep.com may earn a commission when they are used. That never affects what is written here, it is not an endorsement of any vendor, and it is not a statement that anything described on this page is available to buy.
Every claim here ties to a named primary source and a date, written as plain documentation with nothing for sale. That is how MD PEP covers the whole peptide market.
